{
  "id": "ACC-AHA_Heart_Failure_Staging.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2020-02-15",
      "name": "Maryam Razavi",
      "organisation": " Cambio CDS",
      "email": "maryam.razavi2009@gmail.com"
    },
    "other_contributors": [
      "Isabelle Jensen"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "en": {
        "id": "en",
        "purpose": "- Matches stage to treatment options",
        "keywords": [
          "Heart Failure",
          "Staging"
        ],
        "use": "- Patients with known heart failure.\n- Patients at risk for heart failure.\n\nStage A: High risk for developing HF but no structural disorder of the heart\nStage B: Structural disorder of the heart but has never developed symptoms of HF\nStage C: Past or current symptoms of HF associated with underlying structural heart disease\nStage D: End-stage disease requiring specialized treatment strategies such as mechanical circulatory support, continuous inotropic infusions, cardiac transplantation, or hospice care",
        "misuse": "- Developed jointly by the American College of Cardiology (ACC) and American Heart Association (AHA) to complement, but not replace, the more widely-used New York Heart Association (NYHA) functional classification.",
        "copyright": "@CambioCDS"
      }
    },
    "other_details": {
      "references": "Hunt, S. A., Baker, D. W., Chin, M. H., Cinquegrani, M. P., Feldman, A. M., Francis, G. S. et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: A report of the american college of cardiology/american heart association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the international society for heart and lung transplantation endorsed by the heart failure society of america. Circulation. 2001;104:2996â€“3007"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.acc_aha_heart_failure_staging.v0",
        "template_id": "openEHR-EHR-OBSERVATION.acc_aha_heart_failure_staging.v0",
        "type": "INPUT",
        "elements": {
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0008]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0012]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0017]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0018]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          }
        }
      },
      "gt0003": {
        "id": "gt0003",
        "model_id": "openEHR-EHR-OBSERVATION.acc_aha_heart_failure_staging.v0",
        "template_id": "openEHR-EHR-OBSERVATION.acc_aha_heart_failure_staging.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0030]"
          }
        }
      },
      "gt0016": {
        "id": "gt0016",
        "model_id": "openEHR-EHR-EVALUATION.acc_aha_heart_failure_staging.v0",
        "template_id": "openEHR-EHR-EVALUATION.acc_aha_heart_failure_staging.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0017": {
            "id": "gt0017",
            "path": "/data[at0001]/items[at0003]"
          }
        }
      }
    },
    "rules": {
      "gt0011": {
        "id": "gt0011",
        "priority": 10,
        "when": [
          "$gt0004|Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)|==0|local::at0005|No|",
          "$gt0005|Q2.Patient using cardiotoxins|==0|local::at0009|No|",
          "$gt0006|Q3.Patient with family history of cardiomyopathy|==0|local::at0013|No|"
        ],
        "then": [
          "$gt0010|Stage|=0|local::at0031|Patient does not have substantial risk of HF based ACC/AHA staging guidelines.|"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 9,
        "when": [
          "$gt0004|Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)|==1|local::at0006|Yes|",
          "$gt0005|Q2.Patient using cardiotoxins|!=null",
          "$gt0006|Q3.Patient with family history of cardiomyopathy|!=null",
          "$gt0007|Q4.Patient with previous MI, LV systolic dysfunction, or asymptomatic valvular disease(If yes go to Q5)|==0|local::at0020|No|"
        ],
        "then": [
          "$gt0010|Stage|=1|local::at0032|A- High risk for developing HF but no structural disorder of the heart|"
        ]
      },
      "gt0013": {
        "id": "gt0013",
        "priority": 8,
        "when": [
          "$gt0004|Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)|==1|local::at0006|Yes|",
          "$gt0005|Q2.Patient using cardiotoxins|!=null",
          "$gt0006|Q3.Patient with family history of cardiomyopathy|!=null",
          "$gt0007|Q4.Patient with previous MI, LV systolic dysfunction, or asymptomatic valvular disease(If yes go to Q5)|==1|local::at0021|Yes|",
          "$gt0008|Q5.Patient with known structural heart disease, shortness of breath and fatigue(Reduced exercise tolerance) (If yes go to Q6)|==0|local::at0023|No|"
        ],
        "then": [
          "$gt0010|Stage|=2|local::at0033|B-Structural disorder of the heart but has never developed symptoms of HF|"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 7,
        "when": [
          "$gt0004|Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)|==1|local::at0006|Yes|",
          "$gt0005|Q2.Patient using cardiotoxins|!=null",
          "$gt0006|Q3.Patient with family history of cardiomyopathy|!=null",
          "$gt0007|Q4.Patient with previous MI, LV systolic dysfunction, or asymptomatic valvular disease(If yes go to Q5)|==1|local::at0021|Yes|",
          "$gt0008|Q5.Patient with known structural heart disease, shortness of breath and fatigue(Reduced exercise tolerance) (If yes go to Q6)|==1|local::at0024|Yes|",
          "$gt0009|Q6.Patient with marked heart failure symptoms at rest, despite maximum therapy(Those who are recurrently hospitalized or cannot be safely discharged from the hospital without specialized intervention.)|==0|local::at0026|No|"
        ],
        "then": [
          "$gt0010|Stage|=3|local::at0034|C-Past or current symptoms of HF associated with underlying structural heart disease|"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 6,
        "when": [
          "$gt0004|Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)|==1|local::at0006|Yes|",
          "$gt0005|Q2.Patient using cardiotoxins|!=null",
          "$gt0006|Q3.Patient with family history of cardiomyopathy|!=null",
          "$gt0007|Q4.Patient with previous MI, LV systolic dysfunction, or asymptomatic valvular disease(If yes go to Q5)|==1|local::at0021|Yes|",
          "$gt0008|Q5.Patient with known structural heart disease, shortness of breath and fatigue(Reduced exercise tolerance) (If yes go to Q6)|==1|local::at0024|Yes|",
          "$gt0009|Q6.Patient with marked heart failure symptoms at rest, despite maximum therapy(Those who are recurrently hospitalized or cannot be safely discharged from the hospital without specialized intervention.)|==1|local::at0027|Yes|"
        ],
        "then": [
          "$gt0010|Stage|=4|local::at0035|D-End-stage disease requiring specialized treatment strategies such as mechanical circulatory support, continuous inotropic infusions, cardiac transplantation, or hospice care.|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 5,
        "when": [
          "$gt0010|Stage|==0|local::at0031|Patient does not have substantial risk of HF based ACC/AHA staging guidelines.|"
        ],
        "then": [
          "$gt0017|Management|=0|local::at0009|Patient does not have substantial risk of HF based ACC/AHA staging guidelines.|"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 4,
        "when": [
          "$gt0010|Stage|==1|local::at0032|A- High risk for developing HF but no structural disorder of the heart|"
        ],
        "then": [
          "$gt0017|Management|=1|local::at0010|Therapy considerations:Treat hypertension;Encourage smoking cessation;Treat lipid disorders;Encourage regular exercise;Discourage alcohol intake/illicit drug use;ACE inhibitors in appropriate patients.|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 3,
        "when": [
          "$gt0010|Stage|==2|local::at0033|B-Structural disorder of the heart but has never developed symptoms of HF|"
        ],
        "then": [
          "$gt0017|Management|=2|local::at0011|All measures under stage A;ACE inhibitors in appropriate patients;Beta-blockers in appropriate patients.\r\n|"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 2,
        "when": [
          "$gt0010|Stage|==3|local::at0034|C-Past or current symptoms of HF associated with underlying structural heart disease|"
        ],
        "then": [
          "$gt0017|Management|=3|local::at0012|All measures under stage A;Diuretics, ACE inhibitors, beta-blockers, or digitalis for routine use; Dietary salt restriction.\r\n|"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 1,
        "when": [
          "$gt0010|Stage|==4|local::at0035|D-End-stage disease requiring specialized treatment strategies such as mechanical circulatory support, continuous inotropic infusions, cardiac transplantation, or hospice care.|"
        ],
        "then": [
          "$gt0017|Management|=4|local::at0013|All measures under stage A, B and C; Mechanical assist devices; Heart transplantation; Continuous IV inotropic infusions for palliation; Hospice care.|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "ACC-AHA-Heart-Failure-Staging",
            "description": "Describes stages of heart failure and provides recommendations for therapy by stage.\n"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Q1.Patient with history of hypertension, coronary artery disease, OR diabetes (If yes go to Q4)",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Q2.Patient using cardiotoxins",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Q3.Patient with family history of cardiomyopathy",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Q4.Patient with previous MI, LV systolic dysfunction, or asymptomatic valvular disease(If yes go to Q5)",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Q5.Patient with known structural heart disease, shortness of breath and fatigue(Reduced exercise tolerance) (If yes go to Q6)",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Q6.Patient with marked heart failure symptoms at rest, despite maximum therapy(Those who are recurrently hospitalized or cannot be safely discharged from the hospital without specialized intervention.)",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Stage",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Stage N/A"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Stage A"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Stage B"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Stage C"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Stage D"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Management",
            "description": "*"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Management Stage A"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Management Stage B"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Management Stage C"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Management Stage D"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Management Stage 0"
          }
        }
      }
    }
  }
}